SITE012-0076

SITE012 (BRA) › SITE012-0076

SITE012-0076

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2025-11-28

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-15 (study day 285); relationship: not assessed

mild assessed

Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-08-18 (study day 76); relationship: not assessed

moderate assessed

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-07-21 (study day 48); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.